
### [NCIT:C40389](http://purl.obolibrary.org/obo/NCIT_C40389)
**Label:** Breast Myoepithelial Tumor

**Subclasses:** [NCIT:C40388](http://purl.obolibrary.org/obo/NCIT_C40388) (Periductal Breast Myoepitheliosis), [NCIT:C40395](http://purl.obolibrary.org/obo/NCIT_C40395) (Malignant Breast Myoepithelioma), [NCIT:C40385](http://purl.obolibrary.org/obo/NCIT_C40385) (Breast Myoepitheliosis), [NCIT:C6899](http://purl.obolibrary.org/obo/NCIT_C6899) (Breast Adenomyoepithelioma), [NCIT:C5143](http://purl.obolibrary.org/obo/NCIT_C5143) (Malignant Breast Adenomyoepithelioma), [NCIT:C5144](http://purl.obolibrary.org/obo/NCIT_C5144) (Benign Breast Adenomyoepithelioma), 

**Class expressions from DL-Learner:**

- [NCIT:C36780](http://purl.obolibrary.org/obo/NCIT_C36780) (Malignant Myoepithelial Cell) 62.50%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and [NCIT:C36807](http://purl.obolibrary.org/obo/NCIT_C36807) (Dysplastic Epithelial Cell) 62.50%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and [NCIT:C36779](http://purl.obolibrary.org/obo/NCIT_C36779) (Malignant Epithelial Cell) 62.50%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) 62.50%
- Thing 52.03%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) 47.86%
- [NCIT:C36769](http://purl.obolibrary.org/obo/NCIT_C36769) (Abnormal Myoepithelial Cell) 47.86%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39130](http://purl.obolibrary.org/obo/NCIT_C39130) (Insulin Signaling Pathway))) 47.86%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39128](http://purl.obolibrary.org/obo/NCIT_C39128) (IL7 Signaling Pathway))) 47.86%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39124](http://purl.obolibrary.org/obo/NCIT_C39124) (IL3 Signaling Pathway))) 47.86%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39123](http://purl.obolibrary.org/obo/NCIT_C39123) (IL2RB Pathway))) 47.86%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39121](http://purl.obolibrary.org/obo/NCIT_C39121) (IL22 Signaling Pathway))) 47.86%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39117](http://purl.obolibrary.org/obo/NCIT_C39117) (IL12 Signaling Pathway))) 47.86%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 47.86%
- [NCIT:C36770](http://purl.obolibrary.org/obo/NCIT_C36770) (Neoplastic Myoepithelial Cell) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 47.86%


